Abstract

Squamous cell cancer of the head and neck (SCCHN) often requires adjuvant radiotherapy. Radiotherapy for SCCHN is a challenge because the head and neck contain several critical organs that should receive minimal doses of radiation. These organs include the eyes, parotid glands, brainstem, spinal cord, mandible, and thyroid gland. Approaches like image-guided radiotherapy (IGRT) combined with volumetric modulated arc therapy hold the promise to focus radiation to the planning target volume and spare nearby structures while observing potential changes to patient anatomy during treatment to determine whether replanning is required. IGRT, however, requires the frequent imaging of patients to update the treatment plan. In this retrospective study, we present our findings of SCCHN patients treated in a public hospital in Peru. The patients reflected overall demographic trends associated with SCCHN. Each patient was imaged using computed tomography once before radiotherapy and once by cone-beam computed tomography (CBCT) during treatment, for a total of two images. Tumor displacement, planning target volume, gross tumor volume, and neck diameter were compared between the two images. Among the measurements, only a small statistically significant increase in gross tumor volume was observed between the images. However, a minority of patients did experience changes to anatomy, which highlights the need for continued research into criteria to determine which patients are likely to benefit from treatment replanning due to intra-treatment anatomical changes. Alternatively, a lack of frequent CBCT imaging before each session, due to high patient flows and limited staff resources, made it difficult to observe transient changes and trends in each patient. We conclude that the treatment and outcome improvements associated with IGRT are likely associated with frequent imaging during radiotherapy and properly selecting which patients will benefit most from this resource-intensive technique.

Highlights

  • Each year, there are more than 500,000 new worldwide cases of squamous cell cancer of the head and neck (SCCHN) [1]

  • Inclusion criteria included a histological diagnosis of SCCHN, staged at T3-T4 N0 or T1-T4 N1-N3, age greater than 18 years, ECOG 1-2, and treatment using bilateral neck RT with intensity-modulated radiation therapy (IMRT) with conventional fractionation and treatment planning occurring before treatment

  • A cohort of sequential patients treated at the radiotherapy center between February 2018 and March 2021 that met inclusion criteria was used for this study

Read more

Summary

Introduction

There are more than 500,000 new worldwide cases of squamous cell cancer of the head and neck (SCCHN) [1]. RT would deliver a high dose of ionizing radiation to the tumor, spare healthy tissue outside of the planning target volume, account for anatomical changes that take place during treatment, and maximize efficient use of equipment and specialist time. This is of particular challenge to radiotherapy (RT) because the head and neck contain several critically important organs, such as the eyes, parotid glands, brainstem, spinal cord, mandible, and thyroid gland

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call